Business
VIMAB: Sales up 22% year-over-year, losses narrowed, and energy segment showed strong growth
VIMAB: Sales up 22% year-over-year, losses narrowed, and energy segment showed strong growth
About this update from Vimab Group Ab
Net sales rose 22% year-over-year to 67.5 MSEK, with improved EBITDA and operating results. Vimab AB posted its best Q1 ever, and VIM Energy Systems expanded in battery systems and energy trading. Cash flow was negative due to high working capital.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.